Rare diseases
Investigational molecules
Locations
Back to France39 clinical trials in Boulogne sur Mer, France. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on Pioglitazone for Improving Kidney Health in Patients with ANCA-Associated Vasculitis
FranceStudy on the Safety and Tolerability of Lixudebart and Rituximab for Patients with Rapidly Progressive Glomerulonephritis Due to ANCA-Associated Vasculitis
FranceStudy Comparing FOLFIRINOX and Cisplatin-Etoposide for Patients with Metastatic Gastroenteropancreatic Neuroendocrine Carcinoma
FranceStudy on Landiolol Hydrochloride and Sodium Chloride for Reducing Mortality in Patients with Septic Shock and High Heart Rate
FrancePhase III Randomized Study of Balcinrenone and Dapagliflozin Versus Dapagliflozin on Renal and Cardiovascular Outcomes in Patients with Chronic Kidney Disease Stage 3b‑4
FranceStudy of Avacopan Safety and Effectiveness in Patients with ANCA-associated Vasculitis
FranceEffectiveness of Tenecteplase in Acute Ischemic Stroke Patients Treated 4.5–24 Hours After Onset Before Transfer for Thrombectomy
FranceStudy evaluating the omission of exemestane, letrozole, anastrozole, and tamoxifen in postmenopausal women with low-risk early breast cancer.
FranceCarboplatin‑based drug combination for advanced non‑small cell lung cancer patients with interstitial lung disease
FranceTesting avacopan added to standard treatment in patients with ANCA-associated vasculitis with severe kidney damage
FranceStudy of rituximab and glucocorticoids versus placebo and glucocorticoids in adults with newly diagnosed or relapsing IgA vasculitis
FranceStudy on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke
FranceThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking clinical trials exploring treatments for various cancers, with focus on pancreatic adenocarcinoma, breast cancer, and colorectal cancer. Studies evaluate novel therapeutic approaches including targeted therapies and immunotherapy combinations.
Advanced research includes evaluation of treatment efficacy in hormone receptor-positive breast cancer and hepatocellular carcinoma.
Innovative trials investigating treatments for chronic kidney disease and cardiovascular conditions. Research focuses on blood thinners, dialysis patients, and prevention of stroke in high-risk populations.
Studies examine novel approaches to treating end-stage renal disease and improving cardiovascular outcomes.
Clinical trials examining treatments for various autoimmune disorders, including ANCA-associated vasculitis, IgA nephropathy, and rheumatoid arthritis. Research evaluates new therapeutic agents and treatment strategies.
Investigations include comparative studies of biological agents and optimization of immunosuppressive therapies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
